Signaling pathways
-
BA2726 dBET6Summary: dBET6 is a highly efficient, selective, cell-permeable, ligand- and ligand-linked PROTAC. -
BA2727 L-AsparaginaseSummary: L-Asparaginase (L-ASNase) is a deamidase that catalyzes the hydrolysis of L-asparagine and L-glutamine and can be used in acute lymphoblastic leukemia. -
BA2728 FB23-2Summary: FB23-2 is a potent and selective inhibitor of mRNAN-methyladenine demethylase. - BA2729 BrusatolSummary: Brusatol (NSC172924) is a unique pathway inhibitor that sensitizes a wide range of cancer cells to Cisplatin and other chemotherapeutically active molecules.
- BA2730 GSK2795039Summary: GSK2795039 is a NADPH oxidase 2 inhibitor that averaged 6 in different cell-free assays.
-
BA2731 IberdomideSummary: Iberdomide (CC-220) is an orally effective (CRBN) E3 ligase modulator. - BA2732 IsoginkgetinSummary: Isoginkgetin is an inhibitor.
- BA2733 WM-3835Summary: WM-3835 is a potent, highly specific(or) inhibitor.
- BA2734 RaptinalSummary: Direct activation of Raptinal initiates apoptosis-dependent endogenous pathways.
- BA2735 HA15Summary: HA15 is a potent and specific inhibitor of endoplasmic reticulum chaperonin.